Thread by @BigBiteNow

(1/4)

There is a valid argument to be had that #GDR disrespected their shareholders with the 80p last week.

However, the raise has to be taken in the context of the bigger picture and what GDR are attempting to achieve, in a very short period of time.

Here's a theory.

(2/4)

GDR have a pre-order in for the raw materials for 6m tests, raw materials that are in short supply.

They go live with their product in May.

Proceeds of raise are due end of May.

(3/4)

So perhaps this raise had to be put to bed now, in order to secure significant first production quickly and open the company up to significant revenues and in turn, exploit further more expansive production.

That would mean GDR working that raise, despite a spike in SP.

(4/4)

If so, then the pain would be necessary for further shareholder gain.

Gains that are hard to appreciate whilst the effects of the raise are still being felt, which itself remains completely understandable.

(4a)

A big thank to LSE BB contributor Invest4theLT for posting.

#GDR test CE mark planned for w/c 18th May and "available for distribution shortly thereafter."

mobile.crowdicity.com/testingmethods…

(4b)

"Manufacturing capacity to several million of tests per month after scaling. . . We expect non-UK demand for this product as well."

Raw materials are a risk but "significant supply chain commitments already in place."

(4c)

GDR are so close to being ready to go but really needed that cash injection to open themselves up to those "several million tests per month."

Hit those sorts of sales at 60% gross margin and the raise will be history.